Science Explorer Back to mapMap
Discussion
Researcher · Merck KGaA, Darmstadt (Germany) · Germany

Anja von Heydebreck

Anja von Heydebreck publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Gene expression and cancer classification and Lung Cancer Treatments and Mutations.

OpenAlex
World rank
#398,596
of 7,710,434 ranked researchers
Rank in Germany
#19,612
of 364,343
Works
121
Citations
11k
Citations per work
90.7
h-index
41
i10-index 70Top 6% in Oncology
Anja von Heydebreck

What does Anja von Heydebreck research?

Anja von Heydebreck's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (16%).

Health Sciences: 68 works · 56.1% of their workMedicine: 68 works · 56.1% of their workOncology: 29 works · 23.8% of their workPulmonary and Respiratory Medicine: 21 works · 17.0% of their workSurgery: 8 works · 6.3% of their workGastroenterology: 6 works · 5.1% of their workRadiology, Nuclear Medicine and Imaging: 5 works · 3.9% of their workEverything else: 33 works · 27.5% of their workLife Sciences: 20 works · 16.4% of their workBiochemistry, Genetics and Molecular Biology: 20 works · 16.4% of their workMolecular Biology: 20 works · 16.4% of their workTHEIR WORKAnja vonHeydebreck121works
Life Sciences16%Health Sciences56%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine6856.1%
  2. Everything else3327.5%
    1. Biochemistry, Genetics and Molecular Biology2016.4%
  1. 1Oncology24% of their works
  2. 2Pulmonary and Respiratory Medicine17% of their works
  3. 3Molecular Biology16% of their works
  4. 4Surgery6% of their works
  5. 5Gastroenterology5% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Anja von Heydebreck's research?

The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, Gene Expression and Microarray.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Immune Checkpoint Blockade311 topic
  2. PD-1 and PD-L1311 topic
  3. Targeted Therapy292 topics
  4. Chemotherapy212 topics
  5. ALK Inhibitors181 topic
  6. EGFR Mutations181 topic
  7. Gene Expression181 topic
  8. Microarray181 topic
  9. Imatinib Mesylate171 topic
  10. Sunitinib171 topic
  11. Merkel Cell Carcinoma151 topic
  12. Polyomavirus151 topic
  13. Cancer Genomics111 topic
  14. Endoscopic Resection111 topic
  15. Gastric Cancer111 topic
  16. Mutational Signatures111 topic
  17. Cetuximab101 topic
  18. KRAS Mutations101 topic

Where does Anja von Heydebreck work?

Anja von Heydebreck's main affiliation in the publication record is Merck KGaA, Darmstadt (Germany), Germany.

How many publications and citations does Anja von Heydebreck have?

OpenAlex counts 121 works and 10,969 citations for Anja von Heydebreck, an h-index of 41, ranking #398,596 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Anja von Heydebreck. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.